[Summary] It is a high-tech pharmaceutical R&D and production enterprise integra
Founded in 1996 and headquartered in California, USA, Amphastar is a recognized specialty pharmaceutical company that uses state-of-the-art cGMP-compliant facilities for the development, production and sale of injectables and inhalants.
Amphastar is listed on NASDAQ under the ticker symbol "AMPH". Its subsidiaries are located across the United States, China and Europe.
Amphastar (Nanjing) Pharmaceutical Co., Ltd., founded in 2009, is a controlled subsidiary of Amphastar, USA, and is located at No. 5 Xinghe Road, Nanjing Economic and Technological Development Zone, Qixia District, Nanjing, Jiangsu Province.
Amphastar (Nanjing) Pharmaceutical Co., Ltd. focuses on the R&D, production and sales of biologics, APIs and formulations, and has five platforms: finished drug R&D, API R&D, analytical technical services, clinical trials and entrepreneurial incubation.
The company currently has about 500 employees and is a young and innovative team.
Amphastar (Nanjing) Pharmaceutical Co., Ltd. welcomes you to join us!
* The company has now launched city shuttle buses (Jiangning, Maigaogiao, Xianlin) and Jiangbei shuttle buses (Tianruncheng, Nanjing University of Information Science and Technology, Dachang).
What does Amphastar (Nanjing) Pharmaceutical Co., Ltd. require? Who is Amphastar Nanjing hiring? Amphastar Nanjing recruitment: 工厂生产类占比最多占64.3%,其次是生物/制药/化工/环保类占57.1%. What education can get in at Amphastar Nanjing? 大专占比最多占50%,其次是高中占26.2%. High education required at Amphastar Nanjing? 硕士占2.4%. Work experience required at Amphastar Nanjing? 不限占比最多占54.8%,其次是1-3年占38.1%. Where are the job locations at Amphastar Nanjing? 南京占比最多占100%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows